The substantiation of the role of a clinical pharmacist in preventing antibiotic resistance
DOI:
https://doi.org/10.24959/sphhcj.23.304Keywords:
clinical pharmacy; antibacterial drug; prevention; antibiotic resistance.Abstract
Aim. To study the role of a clinical pharmacist in overcoming antibiotic resistance in healthcare institutions that provide both primary (outpatient) and specialized (inpatient) medical care.
Materials and methods. The research materials were the Order of the Ministry of Health of Ukraine No. 1513 of 23.08.2023 “The rational use of antibacterial and antifungal drugs for therapeutic and preventive purposes”. Such methods as analysis, synthesis, grouping, formal-dogmatic, logical-semantic, ascent from abstract to concrete, historical, comparative, systematic, graphic ones were used.
Results. According to the results of the analysis of the new standard of medical care “The rational use of antibacterial and antifungal drugs for therapeutic and preventive purposes”, it can be noted that clinical pharmacists are responsible for promoting, managing and optimizing the use of antimicrobial drugs. It is the level of professional training, qualification and experience in working with infectious diseases that allow clinical pharmacists to be leaders of programs to combat antibiotic resistance.
Conclusions. According to the provisions of the Standard, the clinical pharmacist should be in close cooperation with the doctor through counseling. An important aspect of preventing complications of antibacterial pharmacotherapy and developing antibiotic resistance is a retrospective audit of antibacterial drug prescriptions performed by a clinical pharmacist. Taking into account the above, in our opinion, it will be rational to include the elements of practical training on prospective counseling and retrospective audit of the use of antibacterial agents in the working program of “Clinical Pharmacy and Pharmaceutical Care” for applicants of higher education of the educational and professional program “Clinical Pharmacy”.
References
Antimicrobial resistance surveillance in Europe 2022–2020 (2022). WHO Regional Office for Europe. Available at: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data.
Reza Ranjbar, Mostafa Alam (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. BMJ Journals. Available at: https://ebn.bmj.com/content/early/2023/07/26/ebnurs-2022-103540.
Poku, E., Cooper, K., Cantrell, A., Harnan, S., Abu Sin, M., Zanuzdana, A. (2023). Systematic review of time lag between antibiotic use and rise of resistant pathogens among hospitalized adults in Europe. JAC Antimicrob. Resist., 5 (1). dlad001. Available at: https://pubmed.ncbi.nlm.nih.gov/36694849/.
Lai, W. M., Islahudin, F. H., Ambaras, K. R., Chong, W. W. (2022). Pharmacists’ Perspectives of Their Roles in Antimicrobial Stewardship: A Qualitative Study among Hospital Pharmacists in Malaysia. Antibiotics (Basel). 9, 11 (2), 219. Available at: https://pubmed.ncbi.nlm.nih.gov/35203822/.
European Society of Clinical Pharmacy (2023). Available at: http://www.escpweb.org.
Jantarathaneewat, K., Camins, B., Apisarnthanarak, A. (2022). The role of the clinical pharmacist in antimicrobial stewardship in Asia: A review. Antimicrobial Stewardship & Healthcare Epidemiology, 2(1). doi:10.1017/ash.2022.310.
The Role of a Pharmacist in Encouraging Prudent Use of Antibiotics and Averting Antimicrobial Resistance: A Review of Policy and Experience in Europe (2014). Geneva : World Health Organization. Available at: https://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/publications/2014/.
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K., Wertheim H. F. Sumpradit, N. (2013). Antibiotic resistance-the need for global solutions. Lancet Infect Dis., 13 (12), 1057-98. doi:10.1016/S1473-3099(13)70318-9.
Landesapothekerkammer Thüringen. (2023). Leitlinien der Bundesapothekerkammer zur Qualitätssicherung. Available at: https://www.lakt.de/aktuell/bereich-0/artikel-4896/leitlinien-der-bundesapothekerkammer-zur-qualitaetssicherung.
St Louis, J., Okere, A. N. (2021). Clinical impact of pharmacist-led antibiotic stewardship programs in outpatient settings in the United States: A scoping review. Am J Health Syst Pharm. 22;78 (15), 1426-1437. doi:10.1093/ajhp/zxab178.
Standart medychnoi dopomohy: Ratsionalne zastosuvannia antybakterialnykh i antyfunhalnykh preparativ z likuvalnoiu ta profilaktychnoiu metoiu. Kyiv, 2023. Available at: https://moz.gov.ua/uploads/9/49094-dn_1513_23082023_dod.pdf.
AWaRe classification of antibiotics for evaluation and monitoring of use. (2023). Available at: https://www.who.int/southeastasia/publications/i/item/WHO-MHP-HPS-EML-2023.04.
Instruktsiia z vprovadzhennia administruvannia antymikrobnykh preparativ v zakladakh okhorony zdorovia, yaki nadaiut medychnu dopomohu v statsionarnykh umovakh : nakaz MOZ Ukrainy vid 03.08.2021 r. No. 1614. Available at: https://zakon.rada.gov.ua/laws/show/z1322-21#Text.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
